Cresco Labs Inc.
CL
Rank in Stocks
#16928
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing... Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
Share Price
$0.53110881
Last synced: 2026-11-09
Market Cap
$188.08M
Change (1 day)
-5.06%
Change (1 year)
-50.64%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cresco Labs Inc. (CL)
Category
Healthcare
EPS for Cresco Labs Inc. (CL)
EPS as of June 2026 TTM: $-0.29
According to Cresco Labs Inc.'s latest financial reports, its current EPS (TTM) is $-0.29. At the end of 2025 the company had an EPS of $-0.42, a decrease compared to its 2024 EPS of $-0.22.
EPS history for Cresco Labs Inc. from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.29 | -30.95% |
| 2025 | $-0.42 | 90.91% |
| 2024 | $-0.22 | -58.49% |
| 2023 | $-0.53 | -25.35% |
| 2022 | $-0.71 | -41.80% |
| 2021 | $-1.22 | 617.65% |
| 2020 | $-0.17 | -69.64% |
| 2019 | $-0.56 | 1,766.67% |
| 2018 | $-0.03 | -99.03% |
| 2017 | $-3.10 | -327.94% |
| 2016 | $1.36 | -140.24% |
| 2015 | $-3.38 | -41.92% |
| 2014 | $-5.82 | -43.93% |
| 2013 | $-10.38 | 835.14% |
| 2012 | $-1.11 | -98.57% |
| 2011 | $-77.44 | -28.46% |
| 2010 | $-108.25 | 38.36% |
| 2009 | $-78.24 | 224.11% |
| 2008 | $-24.14 | -45.61% |
| 2007 | $-44.38 | -37.53% |
| 2006 | $-71.04 | 143.79% |
| 2005 | $-29.14 | -33.64% |
| 2004 | $-43.91 | 2,394.89% |
| 2003 | $-1.76 | -113.24% |
| 2002 | $13.29 | -115.31% |
| 2001 | $-86.80 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -2,341.86% |
DE
|
|
| $6.08 | -2,195.72% |
DE
|
|
| $1.55 | -634.69% |
JP
|
|
| $3.66 | -1,362.07% |
CH
|
|
| $0.45 | -255.17% |
IL
|
Questions about Cresco Labs Inc.'s earnings per share (EPS)
What is Cresco Labs Inc.'s earnings per share (EPS)?
Cresco Labs Inc.'s earnings per share (EPS) over the last twelve months is $-0.29, as of Jun 2026.
What was Cresco Labs Inc.'s earnings per share (EPS) in 2025?
In 2025, Cresco Labs Inc.'s earnings per share (EPS) was $-0.42, compared with $-0.22 in 2024.
How has Cresco Labs Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cresco Labs Inc.'s earnings per share (EPS) was highest in 2020 ($-0.17) and lowest in 2021 ($-1.22).
How does Cresco Labs Inc.'s earnings per share (EPS) compare with similar companies?
Cresco Labs Inc.'s earnings per share (EPS) ($-0.29) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.